Opportunities

Abode is good because ...

Body Rocket (or the "Company") is a next-generation of cycling performance technology: a compact, bike-mounted system that delivers real-time aerodynamic and biomechanical insight on real rides. While athletes train by data (power, heart rate, cadence and GPS), aerodynamics—the biggest determinant of speed at race pace—remains largely inaccessible outside elite teams with wind-tunnel access. BodyRocket brings that capability into the field, helping serious cyclists, coaches and performance teams optimise position, clothing and bike setup—where gains of up to ~20% can be decisive.

The solution

BodyRocket uses four patent-protected sensors positioned at key rider contact points (bars, saddle and pedals) to capture subtle force changes caused by wind resistance during normal riding. AI converts this into an accurate, real-time drag coefficient, effectively replicating wind-tunnel capability outdoors. The system is user-installable, calibrates in ~15 minutes, and weighs ~500g. Integrated power measurement enables deeper analysis of efficiency and load.

Market

BodyRocket is targeting the $4.7bn cycling tech market, with long-term expansion into $17bn physical rehabilitation and e-sports. Its core opportunity is the global “Spend on Speed” segment—premium road bikes, aero upgrades, power meters and analytics software purchased for measurable competitive advantage. In the UK & EU, the Serviceable Available Market is c. $1.4bn, with near-term focus on the ~20% of competitive, data-driven riders representing a c. $280m Serviceable Obtainable Market.

Competition

Cycling performance tech is highly fragmented: aerodynamics, power and biomechanics are typically measured in isolation, often via estimation models or lab/studio snapshots. BodyRocket is differentiated by being the only platform that directly measures aerodynamic drag forces on-bike (validated against wind tunnels) while integrating power and biomechanics into a unified real-time dataset—a structural advantage that supports defensibility across hardware, SaaS and future OEM channels.

Commercial overview

BodyRocket operates a three-channel model:

• Hardware as the entry point (current products c. £1,250–£6,000; broader consumer “Aero” product planned in 2028 at c. £990).
• SaaS subscriptions from September 2026, delivering recurring, high-margin revenue via AI-driven analytics and remote collaboration between athletes and experts.
• OEM licensing from 2028, embedding BodyRocket’s IP and AI engine into mainstream cycling equipment.

Commercial traction

• Body Rocket has achieved early sales across the UK, EU and US. The Company’s primary focus for 2026 is on the UK/EU through 2026, with structured US expansion planned for 2027–28.
• Five distribution partners signed across the UK, Germany, Nordics, UAE and Australia, with exclusivity tied to performance thresholds.
• £650k near-term pipeline including British Cycling, TrainingPeaks Virtual, MyWhoosh and existing distributors.
• Validated by elite adoption: Olympians, world champions and pro teams, with discussions underway for multi-year sponsorship agreements (50+ units).

Abode ...

[BodyRocket has raised £2.3m in equity funding to date, which has been used to build the technical and commercial teams, bring the product to market and secure validation from professional athletes.

The Company is currently raising up to £750k in equity funding at a £4.7m pre-money valuation.

The funding will be used to expand key sales hires, manufacturing scale-up and build in-house tech capability to reduce reliance on outsourced development.]